Stock Analysis

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. So on that note, Allscripts Healthcare Solutions (NASDAQ:MDRX) looks quite promising in regards to its trends of return on capital.

Return On Capital Employed (ROCE): What Is It?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Allscripts Healthcare Solutions, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) รท (Total Assets - Current Liabilities)

0.05 = US$72m รท (US$1.7b - US$253m) (Based on the trailing twelve months to September 2022).

Thus, Allscripts Healthcare Solutions has an ROCE of 5.0%. In absolute terms, that's a low return and it also under-performs the Healthcare Services industry average of 7.5%.

Our analysis indicates that MDRX is potentially undervalued!

roce
NasdaqGS:MDRX Return on Capital Employed December 3rd 2022

Above you can see how the current ROCE for Allscripts Healthcare Solutions compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Allscripts Healthcare Solutions here for free.

How Are Returns Trending?

You'd find it hard not to be impressed with the ROCE trend at Allscripts Healthcare Solutions. We found that the returns on capital employed over the last five years have risen by 118%. That's not bad because this tells for every dollar invested (capital employed), the company is increasing the amount earned from that dollar. In regards to capital employed, Allscripts Healthcare Solutions appears to been achieving more with less, since the business is using 55% less capital to run its operation. If this trend continues, the business might be getting more efficient but it's shrinking in terms of total assets.

In Conclusion...

From what we've seen above, Allscripts Healthcare Solutions has managed to increase it's returns on capital all the while reducing it's capital base. Considering the stock has delivered 32% to its stockholders over the last five years, it may be fair to think that investors aren't fully aware of the promising trends yet. Given that, we'd look further into this stock in case it has more traits that could make it multiply in the long term.

On a separate note, we've found 2 warning signs for Allscripts Healthcare Solutions you'll probably want to know about.

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

โ€ข Connect an unlimited number of Portfolios and see your total in one currency
โ€ข Be alerted to new Warning Signs or Risks via email or mobile
โ€ข Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OTCPK:MDRX

Veradigm

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

Limited growth with weak fundamentals.

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ยท

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25377.2% overvalued
42 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ยท

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
49 users have followed this narrative
7 users have commented on this narrative
15 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ยท

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6411.3% overvalued
8 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

ON
BETA logo
Ontological on Betamek Berhad ยท

Automotive Electronics Manufacturer Consistent and Stable

Fair Value:RM 0.25110.0% overvalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ABNB logo
yiannisz on Airbnb ยท

Airbnb Stock: Platform Growth in a World of Saturation and Scrutiny

Fair Value:US$159.714.2% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ADBE logo
yiannisz on Adobe ยท

Adobe Stock: AI-Fueled ARR Growth Pushes Guidance Higher, But Cost Pressures Loom

Fair Value:US$391.258.6% undervalued
9 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative

Popular Narratives

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ยท

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8685.5% undervalued
82 users have followed this narrative
8 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ยท

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3926.6% undervalued
980 users have followed this narrative
6 users have commented on this narrative
26 users have liked this narrative
RO
RobertoAllende
NVDA logo
RobertoAllende on NVIDIA ยท

The AI Infrastructure Giant Grows Into Its Valuation

Fair Value:US$345.0746.8% undervalued
43 users have followed this narrative
28 users have commented on this narrative
24 users have liked this narrative